Literature DB >> 280156

Acceleration of scrapie in mice by target-organ treatment with interferon inducers.

L B Allen, K W Cochran.   

Abstract

Interferon inducers were used in the target-organ treatment of scrapie in mice. Intracerebral treatments began 24 hr prior to intracerebral inoculation of 10(4.8) LD50 of the Chandler strain of scrapie agent. The treatments included 30 and 0.3 microgram poly(I:C) given weekly 9 times, 45 microgram statolon given biweekly 7 times, or 1.5 HA units of Sendai virus given biweekly 6 times. All treatments except the lower dose of poly(I:C) accelerated death in scrapie-affected mice. Compared to saline-treated control groups, 30 microgram poly(I:C), given weekly, shortened the mean survival time 13.5 days. Groups treated with statolon or Sendai virus had their mean survival times shortened 18.5 and 21.7 days, respectively. Infected mice were also evaluated for signs of disease at approximately weekly intervals using a numerical scoring method. Acceleration was also apparent using this parameter of disease. When treatment occurred only once, Sendai virus was the only inducer to significantly shorten the survival of mice.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 280156     DOI: 10.1111/j.1749-6632.1977.tb22003.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

1.  Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNalpha/beta and IL-1beta responses in the diseased brain and exacerbates chronic neurodegeneration.

Authors:  Robert Field; Suzanne Campion; Colleen Warren; Carol Murray; Colm Cunningham
Journal:  Brain Behav Immun       Date:  2010-04-23       Impact factor: 7.217

2.  Interferon-gamma increases neuronal death in response to amyloid-beta1-42.

Authors:  Clive Bate; Sarah Kempster; Victoria Last; Alun Williams
Journal:  J Neuroinflammation       Date:  2006-03-28       Impact factor: 8.322

3.  Chronic neurodegeneration induces type I interferon synthesis via STING, shaping microglial phenotype and accelerating disease progression.

Authors:  Arshed Nazmi; Robert H Field; Eadaoin W Griffin; Orla Haugh; Edel Hennessy; Donal Cox; Renata Reis; Lucas Tortorelli; Carol L Murray; Ana Belen Lopez-Rodriguez; Lei Jin; Ed C Lavelle; Aisling Dunne; Colm Cunningham
Journal:  Glia       Date:  2019-01-25       Impact factor: 7.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.